Cargando…

Metabolic phenotypes and risk of end-stage kidney disease in patients with type 2 diabetes

BACKGROUND: Obesity often initiates or coexists with metabolic abnormalities. This study aimed to investigate the pathological characteristics and the independent or mutual relations of obesity and metabolic abnormalities with end-stage kidney disease (ESKD) in patients with type 2 diabetes (T2D) an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Lijun, Zou, Yutong, Wu, Yucheng, Cai, Linli, Zhao, Yuancheng, Wang, Yiting, Xiao, Xiang, Yang, Qing, Yang, Jia, Ren, Honghong, Tong, Nanwei, Liu, Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206309/ https://www.ncbi.nlm.nih.gov/pubmed/37234807 http://dx.doi.org/10.3389/fendo.2023.1103251

Ejemplares similares

The association of plasma NT-proBNP level and progression of diabetic kidney disease
por: Zhao, Yuancheng, et al.
Publicado: (2023)

Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease
por: Zou, Yutong, et al.
Publicado: (2022)

Lower bile acids as an independent risk factor for renal outcomes in patients with type 2 diabetes mellitus and biopsy-proven diabetic kidney disease
por: Xiao, Xiang, et al.
Publicado: (2022)

Combining glomerular basement membrane and tubular basement membrane assessment improves the prediction of diabetic end‐stage renal disease
por: Zhao, Lijun, et al.
Publicado: (2021)

Whether Renal Pathology Is an Independent Predictor for End-Stage Renal Disease in Diabetic Kidney Disease Patients with Nephrotic Range Proteinuria: A Biopsy-Based Study
por: Wang, Tingli, et al.
Publicado: (2022)

Sex Differences in Biopsy-Confirmed Diabetic Kidney Disease
por: Wang, Yiting, et al.
Publicado: (2021)

Intravitreal vascular endothelial growth factor inhibitors did not increase the risk of end-stage renal disease in patients with biopsy-proven diabetic kidney disease based on matched study
por: Xiao, Xiang, et al.
Publicado: (2022)

Early-onset of type 2 diabetes mellitus is a risk factor for diabetic nephropathy progression: a biopsy-based study
por: Wu, Yucheng, et al.
Publicado: (2021)

Association between serum uric acid and renal outcome in patients with biopsy-confirmed diabetic nephropathy
por: Zou, Yutong, et al.
Publicado: (2021)

Clinical and Pathological Features of Chinese Patients with Type 2 Diabetes, Biopsy-Proven Diabetic Kidney Disease, and Rapid eGFR Decline
por: Qin, Chunmei, et al.
Publicado: (2022)

Serum transferrin predicts end-stage Renal Disease in Type 2 Diabetes Mellitus patients
por: Zhao, Lijun, et al.
Publicado: (2020)

Solidified glomerulosclerosis, identified using single glomerular proteomics, predicts end-stage renal disease in Chinese patients with type 2 diabetes
por: Zhao, Lijun, et al.
Publicado: (2021)

Implications of a Family History of Diabetes and Rapid eGFR Decline in Patients With Type 2 Diabetes and Biopsy-Proven Diabetic Kidney Disease
por: Wang, Yiting, et al.
Publicado: (2019)

Addition of glomerular lesion severity improves the value of anemia status for the prediction of renal outcomes in Chinese patients with type 2 diabetes
por: Zhao, Lijun, et al.
Publicado: (2022)

Prognostic Nutritional Index as a Predictor of Diabetic Nephropathy Progression
por: Zhang, Junlin, et al.
Publicado: (2022)

Metabolic Surgery to Treat Obesity in Diabetic Kidney Disease, Chronic Kidney Disease, and End-Stage Kidney Disease; What Are the Unanswered Questions?
por: Martin, William P., et al.
Publicado: (2020)

Potential Therapeutic Targeting Neurotransmitter Receptors in Diabetes
por: Pan, Xiaohui, et al.
Publicado: (2022)

The Effects of DPP-4 Inhibitors, GLP-1RAs, and SGLT-2/1 Inhibitors on Heart Failure Outcomes in Diabetic Patients With and Without Heart Failure History: Insights From CVOTs and Drug Mechanism
por: Pan, Xiaohui, et al.
Publicado: (2020)

Weight Loss and Gastrointestinal Hormone Variation Caused by Gastric Artery Embolization: An Updated Analysis Study
por: Tang, Yi, et al.
Publicado: (2022)

Acarbose With Comparable Glucose-Lowering but Superior Weight-Loss Efficacy to Dipeptidyl Peptidase-4 Inhibitors: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
por: Zhang, Fang, et al.
Publicado: (2020)

Comprehensive Lipidome Profiling of the Kidney in Early-Stage Diabetic Nephropathy
por: Hou, Biyu, et al.
Publicado: (2020)

Exploration of Noninvasive Detection of Advanced Glycation End Products in the Lens to Screen for Diabetic Kidney Disease
por: Zhang, Xue-Meng, et al.
Publicado: (2022)

Association between triglyceride-glucose index and risk of end-stage renal disease in patients with type 2 diabetes mellitus and chronic kidney disease
por: Gao, Yue-Ming, et al.
Publicado: (2023)

Derivation and Validation of a Prediction Model of End-Stage Renal Disease in Patients With Type 2 Diabetes Based on a Systematic Review and Meta-analysis
por: Ren, Qiuyue, et al.
Publicado: (2022)

Improvement of Insulin Sensitivity Increases Pregnancy Rate in Infertile PCOS Women: A Systemic Review
por: Liu, Yuqi, et al.
Publicado: (2021)

Effect of iodine nutritional status on the recurrence of hyperthyroidism and antithyroid drug efficacy in adult patients with Graves’ disease: a systemic review
por: Xie, Qingxing, et al.
Publicado: (2023)

Association between serum complements and kidney function in patients with diabetic kidney disease
por: Liu, Meng-chao, et al.
Publicado: (2023)

Characteristics of Serum Thyroid Hormones in Different Metabolic Phenotypes of Obesity
por: Nie, Xiaomin, et al.
Publicado: (2020)

Effect of Glomerular Filtration Rate by Different Equations on Prediction Models for End-Stage Renal Disease in Diabetes
por: Lv, Liangjing, et al.
Publicado: (2022)

Association Between the Triglyceride–Glucose Index and the Incidence of Diabetes in People With Different Phenotypes of Obesity: A Retrospective Study
por: Zou, Su, et al.
Publicado: (2021)

Live Birth Rate of Frozen-Thawed Single Blastocyst Transfer After 6 or 7 Days of Progesterone Administration in Hormone Replacement Therapy Cycles: A Propensity Score-Matched Cohort Study
por: Yang, Xinhong, et al.
Publicado: (2021)

Comparing the effects of endometrial injury in the luteal phase and follicular phase on in vitro fertilization treatment outcomes
por: Wang, Yang, et al.
Publicado: (2022)

REG1A and RUNX3 Are Potential Biomarkers for Predicting the Risk of Diabetic Kidney Disease
por: Wang, Xinyu, et al.
Publicado: (2022)

Evidence From a Systematic Review and Meta-Analysis: Classical Impaired Glucose Tolerance Should Be Divided Into Subgroups of Isolated Impaired Glucose Tolerance and Impaired Glucose Tolerance Combined With Impaired Fasting Glucose, According to the Risk of Progression to Diabetes
por: Liu, Yupu, et al.
Publicado: (2022)

Association of obesity with the development of end stage renal disease in IgA nephropathy patients
por: Wang, Siqing, et al.
Publicado: (2023)

Role of advanced glycation end products on vascular smooth muscle cells under diabetic atherosclerosis
por: Mao, Lin, et al.
Publicado: (2022)

Association of Polycystic Ovary Syndrome Phenotypes With Adverse Pregnancy Outcomes After In-Vitro Fertilization/Intracytoplasmic Sperm Injection
por: Wang, Qiumin, et al.
Publicado: (2022)

Association between atherosclerotic cardiovascular diseases risk and renal outcome in patients with type 2 diabetes mellitus
por: Ren, Honghong, et al.
Publicado: (2021)

Cumulative Live Birth Rate in Patients With Thin Endometrium: A Real-World Single-Center Experience
por: Bu, Zhiqin, et al.
Publicado: (2020)

Transforming Growth Factor-Beta1 in Diabetic Kidney Disease
por: Zhao, Lijun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4p8cmvjbpakr1eesvkhrlgnobb